DE-eSCALation of Opioids Post-surgical dischargE — DESCALE  

Opioid Dependence Clinical Trial

Official title: The Role of the Clinical Pharmacist in Reducing Opioid Dependence at the Interface Between Hospital and Primary Care

Status Recruiting

Clinical Trial Summary

The Descale Study aims to:

1. Look at the prescribing trends of opioids and the scale of long-term use following surgery within East Kent (United Kingdom)

2. Carry out a feasibility study to:

• see if clinical pharmacists can support patients following surgery to manage their post-surgical pain safely and prevent long-term opioid use

• calculate how much it costs the National Health Service (NHS)

• see how the patients experienced the intervention

For Aim 1, historic records of patients who have had surgery and were discharged on opioids will be reviewed. Data collected will include type and strength of pain-relieving medication prescribed; type of surgery; number of additional opioid prescriptions following discharge; use of medical services (e.g., General Practice appointments, physiotherapy); and patient demographics.

For Aim 2, clinical pharmacists will carry out early high-risk medication safety reviews to ensure that patients have their pain managed safely. Investigators will collect key data from patients receiving the clinical pharmacist intervention to see how it affected opioid use, costs and healthcare use. Patients who took part in the study will be invited to participate in an interview and will be asked what they know about opioids and the health risks, and their experiences of the intervention.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Opioid Dependence
• Opioid-Related Disorders

• NCT number: NCT06396663
• Study type: Interventional
• Source: University of Kent
• Contact: Research Coordinator
• Phone: +441227764000
• Email: descalestudy@kent.ac.uk
• Status: Recruiting
• Phase: N/A
• Start date: January 11, 2024
• Completion date: September 2024